Who Exports Norfloxacin from India — 207 Suppliers Behind a $8.3M Market
India's norfloxacin export market is supplied by 207 active exporters who collectively shipped $8.3M across 1,394 shipments. SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with a 14.2% market share, followed by PINNACLE LIFE SCIENCE PRIVATE LIMITED and IPCA LABORATORIES LIMITED. The top 5 suppliers together control 37.4% of total export value, reflecting a moderately competitive market structure.
Top Norfloxacin Exporters from India — Ranked by Export Value
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the leading norfloxacin exporter from India, holding a 14.2% share of the $8.3M market across 1,394 shipments from 207 exporters. The top 5 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, PINNACLE LIFE SCIENCE PRIVATE LIMITED, IPCA LABORATORIES LIMITED, MEDICAMEN BIOTECH LIMITED, ARBRO PHARMACEUTICALS PRIVATE LIMITED — collectively control 37.4% of total export value, indicating a competitive market. Individual shares are: SUN PHARMACEUTICAL INDUSTRIES LIMITED (14.2%), PINNACLE LIFE SCIENCE PRIVATE LIMITED (6.7%), IPCA LABORATORIES LIMITED (6.5%), MEDICAMEN BIOTECH LIMITED (5.4%), ARBRO PHARMACEUTICALS PRIVATE LIMITED (4.6%).
Top Norfloxacin Exporters from India
Ranked by export value · 207 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED NORFLOXACIN TABLETS BPNORLOX 400 NORFLOXACIN BP 400MG 2000000NOSNORMET 100/100 MG SUSPENSION 30 ML BT | $1.2M | 4 | 14.2% |
| 2 | PINNACLE LIFE SCIENCE PRIVATE LIMITED NORFLOXACIN TABLETES BP 400 MG 10X10 EACNORFLOXACIN 400 MG ( EACH TABLET CONTAINNORFLOXACIN 400MG | $552.4K | 3 | 6.7% |
| 3 | IPCA LABORATORIES LIMITED NORFLOXACIN WITH TINIDAZOLE TABLETS ( NONORFLOXACIN WITH TINIDAZOLE TABLETS NOSNORFLOXACIN WITH TINIDAZOLE TABLETS NO | $535.6K | 5 | 6.5% |
| 4 | MEDICAMEN BIOTECH LIMITED NORFLOXACIN TABLETES BP 400 MG 10X10 EACNORFLOXACIN 400 MG ( EACH TABLET CONTAINNORFLOXACIN 400MG | $449.7K | 3 | 5.4% |
| 5 | ARBRO PHARMACEUTICALS PRIVATE LIMITED CIN-TRO SUSPENSION B/NO.AS240087A TO AS240090ANORKIN PLUS SUSPENSION NOS | $377.7K | 3 | 4.6% |
| 6 | EMCURE PHARMACEUTICALS LIMITED NORMET 100/100 MG SUSPENSION 30 ML BTNORFLOXACIN OPHTHALMIC SOLUTION USP 0 3 W V 5 ML FLOXSOL | $374.4K | 3 | 4.5% |
| 7 | LINCOLN PHARMACEUTICALS LTD NORFLOXACIN WITH TINIDAZOLE TABLETS ( NONORFLOXACIN TABLETS BPNORFLOXACIN WITH TINIDAZOLE TABLETS NOS | $281.3K | 2 | 3.4% |
| 8 | EMCURE PHARMACEUTICALS LTD NORMET 100/100 MG SUSPENSION 30 ML BTNORFLOXACIN OPHTHALMIC SOLUTION USP 0 3 W V 5 ML FLOXSOL | $231.9K | 1 | 2.8% |
| 9 | MICRO LABS LIMITED NORFLOXACIN TABLETS BPNORLOX 400 NORFLOXACIN BP 400MG 2000000NOSNORILOX ) ( 10X1 | $205.3K | 3 | 2.5% |
| 10 | AMICO PHARMA | $187.7K | 1 | 2.3% |
| 11 | COMBITIC GLOBAL CAPLET PRIVATE LIMITED CIN-TRO SUSPENSION B/NO.AS240087A TO AS240090ANORKIN PLUS SUSPENSION NOS | $174.3K | 1 | 2.1% |
| 12 | AHLCON PARENTERALS (INDIA) LIMITED NORFLOXACIN OPHTHALMIC SOLUTION USP 0 3 W V 5 ML FLOXSOL | $168.2K | 2 | 2.0% |
| 13 | STRIDES PHARMA SCIENCE LIMITED | $157.2K | 1 | 1.9% |
| 14 | AXELIA NORFLOXACIN WITH TINIDAZOLE TABLETS ( NONORFLOXACIN WITH TINIDAZOLE TABLETS NOSNORMET 100/100 MG SUSPENSION 30 ML BT | $151.1K | 3 | 1.8% |
| 15 | PRASHI PHARMA PRIVATE LIMITED NORFLOXACIN & METRONIDAZOLE TABLETS UNITS : 10X1X10 TABNORMET 100/100 MG SUSPENSION 30 ML BTNORFLOXACIN TABLETS USP.400MG EACH UNCOA | $137.4K | 3 | 1.7% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Norfloxacin exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Approved | Yes (as of September | Yes | Data not available | Sun Pharma's facility in Silvassa is WHO-GMP certified as of September 11, 2025. |
| Emcure Pharmaceuticals Limited | Approved | Yes | Yes | Data not available | Emcure's Hinjawadi facility received an FDA warning letter on August 2, 2019. |
| IPCA Laboratories Limited | Approved | Yes (as of September | Yes | Data not available | IPCA's facilities in Silvassa are WHO-GMP certified as of September 11, 2025. |
| Strides Pharma Science Limited | Approved | Yes | Yes | Data not available | Strides is approved under India's PLI Scheme as of May 3, 2023. |
| Lincoln Pharmaceuticals Ltd | Approved | Yes | Yes | Data not available | Lincoln Pharmaceuticals holds WHO-GMP certification. |
| Micro Labs Limited | Approved | Yes | Yes | Data not available | Micro Labs is WHO-GMP certified. |
| Medicamen Biotech Limited | Approved | Yes | Yes | Data not available | Medicamen Biotech holds WHO-GMP certification. |
| Arbro Pharmaceuticals Private Limited | Approved | Yes | Yes | Data not available | Arbro Pharmaceuticals is WHO-GMP certified. |
TransData Nexus reviewed the regulatory standing of 8 leading Norfloxacin exporters from India. 8 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 8 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Norfloxacin sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes over 40% of the country's bulk drug production. The city hosts numerous manufacturers specializing in Active Pharmaceutical Ingredients (APIs) and intermediates, essential for producing antibiotics like Norfloxacin. Companies such as SVK Laboratories Private Limited and Vasudha Pharma Chem Ltd. exemplify Hyderabad's robust API manufacturing capabilities.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. This region houses several leading companies specializing in the production of finished dosage forms, including tablets and capsules. Notable firms like Alembic Pharmaceuticals, headquartered in Vadodara, have a significant presence in this cluster. Their expertise in formulations makes this region a strategic choice for sourcing ready-to-market Norfloxacin products.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a critical export gateway for India's pharmaceutical products. This region's well-established infrastructure and proximity to major ports facilitate efficient international distribution. Pharmaceutical companies operating here benefit from streamlined logistics, ensuring timely delivery of products like Norfloxacin to global markets.
4Baddi-Nalagarh — Tax Incentive Zone
Located in Himachal Pradesh, the Baddi-Nalagarh region offers attractive tax incentives, making it a favorable zone for pharmaceutical manufacturing. This area has attracted numerous companies seeking cost-effective production solutions. The financial benefits and growing industrial base make Baddi-Nalagarh a viable option for sourcing Norfloxacin.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with manufacturers across different clusters to mitigate risks associated with regional disruptions.
- Evaluate API and Formulation Capabilities: Assess suppliers' expertise in both API production and formulation to ensure comprehensive sourcing solutions.
- Consider Export Logistics: Prioritize suppliers in regions with robust export infrastructure, such as the Mumbai-Thane-Raigad belt, to facilitate efficient international distribution.
- Leverage Cost Advantages: Explore partnerships in tax incentive zones like Baddi-Nalagarh to benefit from cost-effective manufacturing options.
By strategically analyzing India's pharmaceutical clusters, TransData Nexus can optimize its supply chain for Norfloxacin, ensuring reliability, quality, and cost-effectiveness.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Norfloxacin exporters from India
Sun Pharmaceutical Industries Limited — Sun Pharma acquires remaining stake in Taro Pharmaceuticals
In January 2024, Sun Pharma entered into a definitive merger agreement to acquire the remaining stake in Taro Pharmaceuticals for $347.73 million. - IMPACT: This acquisition is expected to enhance Sun Pharma's global market presence, potentially increasing Norfloxacin exports.
Impact: This acquisition is expected to enhance Sun Pharma's global market presence, potentially increasing Norfloxacin exports.
Sun Pharmaceutical Industries Limited — Sun Pharma acquires Checkpoint Therapeutics for $355 million
In March 2025, Sun Pharma announced the acquisition of Checkpoint Therapeutics, a company specializing in immunotherapy and targeted oncology treatments, for $355 million. - IMPACT: This strategic move may diversify Sun Pharma's product portfolio, indirectly affecting Norfloxacin production and export strategies.
Impact: This strategic move may diversify Sun Pharma's product portfolio, indirectly affecting Norfloxacin production and export strategies.
Sun Pharmaceutical Industries Limited — Sun Pharma partners with Pharmazz Inc. for ischemic stroke drug
In September 2023, Sun Pharma entered into a licensing agreement with Pharmazz Inc. to introduce an ischemic stroke drug in India. - IMPACT: This collaboration may lead to resource reallocation, potentially influencing Norfloxacin export volumes.
Impact: This collaboration may lead to resource reallocation, potentially influencing Norfloxacin export volumes.
Common Questions — Norfloxacin Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which norfloxacin supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with 33 recorded shipments worth $1.2M. PINNACLE LIFE SCIENCE PRIVATE LIMITED (8 shipments) and IPCA LABORATORIES LIMITED (20 shipments) are also established high-volume exporters.
Q How many norfloxacin manufacturers are there in India?
India has 207 active norfloxacin exporters with a combined export market of $8.3M across 1,394 shipments to 96 countries. The top 5 suppliers hold 37.4% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for norfloxacin from India?
Average FOB unit price: $6.87 per unit, ranging from $0.01 to $644.01. Average shipment value: $5.9K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 207 verified Indian exporters of Norfloxacin ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 1,394 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 96 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,394 Verified Shipments
207 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists